{"address1": "15825 Shady Grove Road", "address2": "Suite 135", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "410-297-7793", "website": "https://ostherapies.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul A. Romness M.P.H.", "age": 57, "title": "Founder, Chairman, President & CEO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher P. Acevedo", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 36000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert G. Petit Ph.D.", "age": 64, "title": "Chief Medical Officer & Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 300000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack  Doll", "title": "Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerald E. Commissiong", "age": 41, "title": "Chief Business Officer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.54, "open": 1.45, "dayLow": 1.33, "dayHigh": 1.51, "regularMarketPreviousClose": 1.54, "regularMarketOpen": 1.45, "regularMarketDayLow": 1.33, "regularMarketDayHigh": 1.51, "payoutRatio": 0.0, "forwardPE": 0.9047619, "volume": 108434, "regularMarketVolume": 108434, "averageVolume": 1196545, "averageVolume10days": 87220, "averageDailyVolume10Day": 87220, "bid": 1.43, "ask": 0.0, "bidSize": 11, "askSize": 8, "marketCap": 28947850, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 7.0, "fiftyDayAverage": 1.8728, "twoHundredDayAverage": 2.873533, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 30848998, "profitMargins": 0.0, "floatShares": 13917934, "sharesOutstanding": 21765300, "sharesShort": 635931, "sharesShortPriorMonth": 188191, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0292, "heldPercentInsiders": 0.33805, "heldPercentInstitutions": 0.00666, "shortRatio": 0.29, "shortPercentOfFloat": 0.034, "impliedSharesOutstanding": 21765300, "bookValue": -0.033, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -7418772, "trailingEps": -0.35, "forwardEps": 1.47, "enterpriseToEbitda": -6.166, "52WeekChange": -0.47011954, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.33, "targetHighPrice": 20.0, "targetLowPrice": 9.0, "targetMeanPrice": 14.66667, "targetMedianPrice": 15.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 1858104, "totalCashPerShare": 0.087, "ebitda": -5003066, "totalDebt": 0, "quickRatio": 0.719, "currentRatio": 0.763, "returnOnAssets": -2.37776, "grossProfits": -5154, "freeCashflow": -9262876, "operatingCashflow": -5778878, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OSTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "averageDailyVolume3Month": 1196545, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "1.33 - 7.0", "fiftyTwoWeekHighChange": -5.67, "fiftyTwoWeekHighChangePercent": -0.81, "fiftyTwoWeekChangePercent": -47.011955, "preMarketPrice": 1.5484, "regularMarketChange": -0.21, "regularMarketDayRange": "1.33 - 1.51", "fullExchangeName": "NYSE American", "firstTradeDateMilliseconds": 1722519000000, "preMarketChange": 0.2184, "preMarketChangePercent": 16.421053, "fiftyDayAverageChange": -0.54279995, "fiftyDayAverageChangePercent": -0.28983337, "twoHundredDayAverageChange": -1.543533, "twoHundredDayAverageChangePercent": -0.5371551, "priceToBook": -40.303032, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "messageBoardId": "finmb_580518990", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -0.35, "epsForward": 1.47, "epsCurrentYear": 2.57, "priceEpsCurrentYear": 0.51750976, "cryptoTradeable": false, "hasPrePostMarketData": true, "corporateActions": [], "preMarketTime": 1743599313, "regularMarketTime": 1743537600, "exchange": "ASE", "regularMarketChangePercent": -13.6364, "regularMarketPrice": 1.33, "shortName": "OS Therapies Incorporated", "longName": "OS Therapies Incorporated", "marketState": "PRE", "displayName": "OS Therapies", "trailingPegRatio": null}